Xu An-Ping, Chen Wei-Dong, Li Jie, Zhou Yu, Zheng Ruo-Yang, Li Xiaofeng, Ji Ling
a Department of Laboratory Medicine , Peking University Shenzhen Hospital , Shenzhen , Guangdong Province , People's Republic of China.
Hemoglobin. 2018 Sep-Nov;42(5-6):330-332. doi: 10.1080/03630269.2018.1540352. Epub 2019 Jan 7.
We report a novel α2-globin chain hemoglobin (Hb) variant in a 23-year-old female of Chinese Han nationality. The Hb variant can be detected by glycated Hb electrophoresis (CapillaryS2, Hb A program). However, Hb fractions analyzed by capillary electrophoresis (CE) (CapillaryS2, Hb program) and high performance liquid chromatography (HPLC), (VARIANT II™ β-Thalassemia Short Program) showed no suspicious Hb variant. Sanger sequencing revealed a novel mutation [α67(E16)Thr→Ile, HBA2: c.203C>T]. We named this novel variant Hb Sichuan after the geographic origin of the proband.
我们报告了一名23岁中国汉族女性中的一种新型α2-珠蛋白链血红蛋白(Hb)变异体。该Hb变异体可通过糖化血红蛋白电泳(CapillaryS2,Hb A程序)检测到。然而,通过毛细管电泳(CE)(CapillaryS2,Hb程序)和高效液相色谱法(HPLC)(VARIANT II™β-地中海贫血短程序)分析的Hb组分未显示可疑的Hb变异体。桑格测序揭示了一种新的突变[α67(E16)苏氨酸→异亮氨酸,HBA2:c.203C>T]。我们根据先证者的地理来源将这种新变异体命名为Hb四川。